MINDCURE Signs Exclusive Digital Clinical Data Licensing Agreement with ATMA Journey Centers Sep 23, 2021
CEO Chris Carl On DigiMax’s Long/Short Crypto Fund : “We Have A Ton Of Institutional Interest” Sep 22, 2021
InMed Pharmaceuticals Positioned For Growth As Cannabinoid Supply Sales Poised For Imminent “Take Off” Sep 22, 2021
Tryp Therapeutics Submits IND Application For Phase 2a Clinical Trial In Eating Disorders Sep 22, 2021
NeonMind Strengthens its Specialty Clinics Advisory Board with Appointment of Mood Disorders and Ketamine Expert Dr.… Sep 22, 2021
